Probiotics for Chronic Constipation

Bifidobacterium lactis strains modestly speed colonic transit and increase stool frequency by roughly one bowel movement per week in meta-analysis. Real, but small — fibre, fluid and movement do more, and probiotics are best used alongside them.

Colonic transit depends substantially on microbial fermentation. Bacteria ferment fermentable fibre into short-chain fatty acids — principally butyrate, acetate and propionate — which lower luminal pH, stimulate colonic smooth muscle contraction, and increase stool water content osmotically. A microbiome with reduced fermentative capacity produces fewer of these signals and slower transit. Specific Bifidobacterium strains also appear to modulate enteric nervous system signalling and serotonin release from enterochromaffin cells, which drives peristalsis. Because the effect depends on fermentable substrate being available, probiotics work considerably better when fibre intake is adequate — supplementing bacteria without feeding them is half an intervention.

Meta-analyses of probiotics in adults with functional constipation report an increase in weekly stool frequency of approximately one bowel movement and a reduction in whole-gut transit time of roughly twelve hours, with improvements in stool consistency. Bifidobacterium lactis strains, particularly DN-173 010 and HN019, carry most of the positive evidence; Lactobacillus strains have performed less consistently. Effect sizes are genuinely modest and heterogeneity between products is high. Guideline bodies have generally declined to make strong recommendations, and the American Gastroenterological Association's guidance on probiotics recommended against routine use for most gastrointestinal indications outside specific contexts, citing evidence quality. Set against that, probiotics are safe and inexpensive, and constipation is often multifactorial — so a four-week trial alongside the interventions that actually have strong evidence is reasonable, provided expectations are calibrated to one extra bowel movement a week rather than transformation.

People with slow-transit constipation of neurological origin, opioid-induced constipation, untreated hypothyroidism, or pelvic floor dyssynergia — where the problem is coordination of defaecation rather than transit. Anyone eating under 15 g of fibre a day is unlikely to see benefit, since there is nothing for the bacteria to ferment. Structural causes must be excluded in anyone with new constipation over 50, bleeding or weight loss.